Polar Capital Holdings PLC Acadia Pharmaceuticals Inc Transaction History

Polar Capital Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Dec 13, 2023	BUY	$16.32 - $20.92 $4.08 Million - $5.23 Million	250,000 New	250,000 $4.71 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $4.08 Million - $5.23 Million	-250,000 Reduced 50.0%	250,000 $4.71 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $7.06 Million - $9.14 Million	500,000 New	500,000 $8.18 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $1.18 Million - $1.67 Million	-60,879 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $2.55 Million - $5.6 Million	-101,837 Reduced 62.59%	60,879 $1.57 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $6.68 Million - $9.24 Million	162,716 New	162,716 $8.7 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.